Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.20
-0.15 (-2.36%)
At close: Mar 27, 2026, 4:00 PM EDT
6.46
+0.26 (4.24%)
After-hours: Mar 27, 2026, 5:01 PM EDT
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $45.7 million as of March 27, 2026. Its market cap has increased by 7.44% in one year.
Market Cap
45.70M
Enterprise Value
-23.85M
1-Year Change
7.44%
Ranking
Category
Stock Price
$6.20
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $325.21M to $45.70M, a decrease of -85.95%. That is a compound annual growth rate of -22.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 45.70M | -0.78% |
| Dec 31, 2025 | 46.06M | -6.05% |
| Dec 31, 2024 | 49.03M | -28.81% |
| Dec 29, 2023 | 68.87M | -85.69% |
| Dec 30, 2022 | 481.38M | -41.42% |
| Dec 31, 2021 | 821.73M | 240.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 50.74M |
| Radiopharm Theranostics | 49.97M |
| Metagenomi Therapeutics | 49.64M |
| Xilio Therapeutics | 49.21M |
| Entera Bio | 49.07M |
| Edesa Biotech | 48.38M |
| Nutriband | 47.90M |
| Lisata Therapeutics | 45.25M |